Another week, another conference. Thousands descended on New Orleans over the weekend — not for Mardi Gras, but for the American Diabetes Association (ADA) conference. The big question: can anyone crack Eli Lilly and Novo Nordisk’s duopoly in obesity and diabetes?
4 min read
Trial Tuesday: The Race To Break The Obesity Duopoly
The needle-shy are the prize now, and four companies showed up to ADA with a pill and a percentage.
